.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Moodys
Argus Health
Express Scripts
Queensland Health
Novartis
QuintilesIMS
Boehringer Ingelheim
Merck

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078638

« Back to Dashboard
NDA 078638 describes ALENDRONATE SODIUM, which is a drug marketed by Impax Labs Inc, West-ward Pharms Int, Sun Pharma Global, Aurobindo Pharma, Mylan, Dr Reddys Labs Ltd, Jubilant Cadista, Austarpharma Llc, Cipla Ltd, Upsher-smith Labs, Apotex, Teva Pharms, and Watson Labs, and is included in fourteen NDAs. It is available from twenty-seven suppliers. Additional details are available on the ALENDRONATE SODIUM profile page.

The generic ingredient in ALENDRONATE SODIUM is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.

Summary for NDA: 078638

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 35MG BASE
Approval Date:Aug 4, 2008TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 70MG BASE
Approval Date:Aug 4, 2008TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Deloitte
McKesson
Farmers Insurance
Baxter
Mallinckrodt
Moodys
Healthtrust
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot